Vancomycin: Clinical Trials

5 trials of Vancomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Unknown 5
Phase 21Unknown 1

Follow Vancomycin: new trials by email Literature Review of Vancomycin trials Research Report on Vancomycin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clostridioides Difficile Colonisation
10E4 NTCD spores, 10E7 NTCD spores, placebo - Clostridioides Difficile Infection
Phase 1UnknownLeiden University Medical Center702023-09-222023-10-17
Application of Fecal Microbiota Transplantation in Children With ASD
Fecal microbiota transplantation, Vancomycin - Autism Spectrum Disorder
Phase 1UnknownTongji Hospital402022-06-012023-01-20
Antibiotics Continuous Infusion at Home
Cefepime, Piperacillin/tazobactam, Meropenem - Severe Bacterial Infections
Phase 1UnknownOspedale San Carlo Borromeo502021-09-012021-03-25
The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy
Vancomycin, Cefazolin - Elective Craniotomy-candidated Patients
Phase 1 / Phase 2UnknownIsfahan University of Medical Sciences1262018-04-012018-03-15
Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution
Vancomycin - Pediatric Continuous Renal Replacement Therapy, Dialysis
Phase 1UnknownDrexel University102017-01-012020-10-19

Conditions studied

Autism Spectrum Disorder (1)  ·  Bacterial Infections (1)  ·  Clostridium Infections (1)  ·  Renal Insufficiency (1)

Sponsors

Drexel University (1)  ·  Isfahan University of Medical Sciences (1)  ·  Leiden University Medical Center (1)  ·  Ospedale San Carlo Borromeo (1)  ·  Tongji Hospital (1)

Countries

China (1)  ·  Iran (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Jeffrey J Cies, PharmD, MPH (1)  ·  Meta Roestenberg, MD, PhD (1)  ·  Vittorio Motefusco, MD (1)